期刊： THERAPEUTIC DRUG MONITORING, 2021; 43 (1)
Background: With the development of industrialization in human society, ambient pollutants are becoming more harmful to human health. Epidemiological ......
期刊： THERAPEUTIC DRUG MONITORING, 2021; 43 (2)
Background: With the outbreak of COVID-19, it has become very important to improve biosafety measures taken by medical staff. Fewer pretreatment steps......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (2)
Background: In the United States, drug addiction has become a nationwide health crisis. Recently, buprenorphine (BUP), a maintenance therapy approved ......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (2)
Background: Antipsychotics are being increasingly prescribed during pregnancy and in the postpartum period. However, knowledge regarding the ability o......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (3)
Background: Tacrolimus dosing is routinely tailored based on its trough level (C-0) drawn by therapeutic drug monitoring in pediatric patients with pr......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (4)
Background: The objective of this study was to investigate the serum concentrations of olanzapine in relation to age, sex, and other factors in Chines......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (4)
Background: In patients with hypoalbuminemia after craniotomy, total serum concentrations of valproic acid (VPA) may provide poor clinical insights, o......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (4)
Background: Vancomycin is a critical antibiotic used in important infections, and therapeutic drug monitoring (TDM) is recommended. Bayesian forecasti......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (4)
Background: Critically ill patients show several pathophysiological alterations that can complicate antibiotic dosing. Hence, there is a strong ration......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (4)
We presented a case of subtherapeutic linezolid concentration in a patient with bullous pemphigoid characterized by large area skin anabrosis complica......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (6)
Background: Interindividual variations in the efficacy of antiseizure medications make epilepsy treatment challenging. This is due to genetic factors ......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (6)
Objective: Tigecycline exerts significant beneficial effects against drug-resistant bacterial infections. The largely empirical medications used in cl......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (5)
Background: The aim of the study was to investigate how age and genetic polymorphisms ofUGT1A6andUGT2B7contribute to the concentrations of valproic ac......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (5)
Background: Cefotiam, a second-generation cephalosporin, is a broad-spectrum antibiotic with good antibacterial action against both gram-negative and ......
期刊： THERAPEUTIC DRUG MONITORING, 2020; 42 (5)
Background: Polymyxin B is used as the last treatment resort for multidrug-resistant gram-negative bacterial infections. This study aimed to develop a......
